Primary |
Infection |
12.0% |
Tooth Infection |
11.5% |
Product Used For Unknown Indication |
7.9% |
Tooth Abscess |
7.8% |
Cellulitis |
6.5% |
Drug Use For Unknown Indication |
5.5% |
Erysipelas |
4.3% |
Antibiotic Therapy |
4.1% |
Osteomyelitis |
4.1% |
Pain |
4.1% |
Sinus Disorder |
4.1% |
Antibiotic Prophylaxis |
3.7% |
Depression |
3.7% |
Staphylococcal Infection |
3.3% |
Hypertension |
3.1% |
Osteitis |
3.1% |
Pharyngitis |
3.0% |
Type 2 Diabetes Mellitus |
3.0% |
Tooth Extraction |
2.8% |
Infection Prophylaxis |
2.6% |
|
Drug Hypersensitivity |
16.0% |
Vomiting |
11.4% |
Rash |
10.2% |
Urticaria |
9.0% |
Diarrhoea |
6.2% |
Drug Eruption |
4.3% |
Pyrexia |
4.3% |
Weight Decreased |
4.3% |
Drug Rash With Eosinophilia And Systemic Symptoms |
4.0% |
Toxic Skin Eruption |
4.0% |
Clostridial Infection |
3.4% |
Hypersensitivity |
3.1% |
Drug Interaction |
2.8% |
Paraesthesia |
2.8% |
Rash Generalised |
2.8% |
Nausea |
2.5% |
Swelling Face |
2.5% |
Dyspepsia |
2.2% |
Dysphagia |
2.2% |
Leukocytoclastic Vasculitis |
2.2% |
|
Secondary |
Drug Use For Unknown Indication |
20.2% |
Product Used For Unknown Indication |
19.6% |
Sepsis |
6.4% |
Pneumonia |
4.7% |
Hypertension |
4.6% |
Prophylaxis |
4.3% |
Rheumatoid Arthritis |
3.9% |
Pain |
3.6% |
Type 2 Diabetes Mellitus |
3.5% |
Cellulitis |
3.4% |
Device Related Infection |
3.4% |
Depression |
3.0% |
Infection |
2.7% |
Metastases To Bone |
2.6% |
Pneumonia Pneumococcal |
2.6% |
Antibiotic Therapy |
2.4% |
Lung Disorder |
2.3% |
Sinusitis |
2.3% |
Pyrexia |
2.2% |
Urinary Tract Infection |
2.2% |
|
Drug Hypersensitivity |
15.2% |
Stevens-johnson Syndrome |
7.6% |
Vomiting |
7.6% |
Rash |
7.0% |
Toxic Epidermal Necrolysis |
6.4% |
Hepatic Enzyme Increased |
5.3% |
Thrombocytopenia |
5.3% |
Death |
4.7% |
Renal Failure Acute |
4.7% |
Drug Rash With Eosinophilia And Systemic Symptoms |
4.1% |
Nausea |
4.1% |
Completed Suicide |
3.5% |
Neutropenia |
3.5% |
Septic Shock |
3.5% |
Urticaria |
3.5% |
Wound Infection |
3.5% |
Pruritus |
2.9% |
Pyrexia |
2.9% |
Diarrhoea |
2.3% |
Drug Eruption |
2.3% |
|
Concomitant |
Drug Use For Unknown Indication |
32.4% |
Product Used For Unknown Indication |
12.6% |
Rheumatoid Arthritis |
8.6% |
Hypertension |
7.1% |
Pain |
6.2% |
Prophylaxis |
5.3% |
Multiple Myeloma |
3.4% |
Depression |
3.1% |
Hiv Infection |
3.0% |
Coronary Artery Disease |
2.3% |
Infection |
1.8% |
Fluid Replacement |
1.8% |
Crohn's Disease |
1.8% |
Non-small Cell Lung Cancer |
1.6% |
Psoas Abscess |
1.6% |
Acne |
1.5% |
Constipation |
1.5% |
Nausea |
1.5% |
Liver Abscess |
1.5% |
Pneumonia |
1.5% |
|
Vomiting |
10.7% |
Weight Decreased |
7.8% |
White Blood Cell Count Decreased |
7.0% |
Systemic Inflammatory Response Syndrome |
6.7% |
Toothache |
5.9% |
Death |
4.8% |
Osteomyelitis |
4.8% |
Sepsis |
4.8% |
Tooth Extraction |
4.8% |
Hypertension |
4.4% |
Pneumonia |
4.4% |
Renal Failure Acute |
4.4% |
Progressive Multifocal Leukoencephalopathy |
4.1% |
Rash |
4.1% |
Thrombocytopenia |
4.1% |
Stevens-johnson Syndrome |
3.7% |
Pulmonary Embolism |
3.3% |
Respiratory Failure |
3.3% |
Swelling Face |
3.3% |
Toxic Epidermal Necrolysis |
3.3% |
|
Interacting |
Product Used For Unknown Indication |
21.4% |
Osteitis |
14.3% |
Cardiac Failure |
9.5% |
Ankylosing Spondylitis |
4.8% |
Back Pain |
4.8% |
Depression |
4.8% |
Drug Use For Unknown Indication |
4.8% |
Fungal Infection |
4.8% |
Hypertension |
4.8% |
Acne |
2.4% |
Anticoagulant Therapy |
2.4% |
Discomfort |
2.4% |
Headache |
2.4% |
Localised Infection |
2.4% |
Migraine |
2.4% |
Muscle Spasms |
2.4% |
Osteoarthritis |
2.4% |
Pain |
2.4% |
Prophylaxis |
2.4% |
Tooth Disorder |
2.4% |
|
Renal Failure Acute |
22.2% |
Drug Interaction |
11.1% |
Drug Level Increased |
11.1% |
Hepatic Function Abnormal |
11.1% |
Mouth Haemorrhage |
11.1% |
Tooth Infection |
11.1% |
Tremor |
11.1% |
Urinary Retention |
11.1% |
|